Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer. Zhou Q, Zhao J, Chang J, Wang H, et al. Cancer 2023 Jun 6. doi: 10.1002/cncr.34897.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhou Q, Zhao J, Chang J, Wang H, et al. Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer. Cancer 2023 Jun 6. doi: 10.1002/cncr.34897.
PMID: 37282666